Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)
Bicycle Therapeutics (BCYC) reported Current Leases of $2.6 million for Q4 2025, up 1357.71% on a YoY basis from $175000.0 in Q4 2024, and up 1181.91% quarter-over-quarter from $199000.0 in Q2 2025.
Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025) Analysis & Trends
Bicycle Therapeutics has reported Current Leases for 7 years, with the latest figure at $2.6 million in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 1357.71% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $2.6 million (up 1357.71% YoY), and the FY2025 full-year result was $2.6 million, up 1357.71% from the prior year.
- Current Leases for Q4 2025 stood at $2.6 million, up from $199000.0 in the prior quarter.
- The five-year high for Current Leases was $5.4 million in Q3 2024, with the low at $175000.0 in Q4 2024.
- Historically, Current Leases has averaged $2.8 million across 5 years, with a median of $2.9 million in 2022.
- Annual changes were most pronounced in 2024 — Current Leases plunged 96.41% — and 2025, when it soared 1357.71%.
- Bicycle Therapeutics' Current Leases stood at $2.4 million in 2021, then soared by 31.14% to $3.1 million in 2022, then jumped by 56.03% to $4.9 million in 2023, then sank by 96.41% to $175000.0 in 2024, then soared by 1357.71% to $2.6 million in 2025.
- The last three Current Leases figures came in at $2.6 million (Q4 2025), $199000.0 (Q2 2025), and $184000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicycle Therapeutics | 278.04 Mn | 278.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.55 Mn |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 708,000.00 |
| Dec 31, 2020 | 844,000.00 |